The Longevity Genes in Founder Populations Project

Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00707694

Enrollment

2000

Registered

2008-07-01

Start date

1998-07-31

Completion date

2032-12-31

Last updated

2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extreme Longevity

Keywords

95 years of age and older

Brief summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

65 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Ashkenazi Jewish, age 95+, * Offspring of person age 95+, * Offspring of parents who died age 70 or younger.

Exclusion criteria

* Non-Ashkenazis

Countries

United States

Contacts

Primary ContactTina Gao

tina.gao@einsteinmed.edu718-839-7176

Outcome results